Search
Bio Rad Laboratories Inc
BIOAdd to Watchlist
325.480USD
-0.980-0.30%
Close 07-31 16:00（ET）Quotes delayed by 15 min
8.63BMarket Cap
53.98P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Bio Rad Laboratories Inc is 6.33, ranking 169 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 365.00, with a high of 375.00 and a low of 325.00.
Analyst Rating
Based on
6
analysts
Hold
Current Rating
308.000
Target Price
-5.88%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Bio Rad Laboratories Inc
BIO
6
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Bio Rad Laboratories Inc's expected revenue for the next quarter?
Bio Rad Laboratories Inc's expected revenue is 623.99M.
What is Bio Rad Laboratories Inc's price target?
Analysts forecast that Bio Rad Laboratories Inc's price target is USD 365.00, with the highest forecast at USD 375.00 and the lowest forecast at USD 325.00.
How have Bio Rad Laboratories IncBIO's recent earnings per share performed?
The market expectation was USD -19.55, while Bio Rad Laboratories IncBIO's earnings per share (EPS) for the previous quarter was USD 26.69. EPS for the next quarter is expected at USD 1.75.
What is the analyst rating for Bio Rad Laboratories Inc?
Based on the ratings of Bio Rad Laboratories Inc's stock from 6 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.